Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DEBBIE DEVINE

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Obstetrics & Gynecology

NPI
1578614590
CMS profile
10499992
Location
TAMPA, FL

General Payments · PY2021–2024

$3,095.60

  • Reported across 37 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$948.78

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $948.78 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $318.48 3
Corcept Therapeutics $149.18 5
Neurocrine BioSciences, Inc. $124.95 1
Acerta Pharma LLC $121.24 1
BOSTON SCIENTIFIC CORPORATION $90.39 1
SANOFI-AVENTIS U.S. LLC $85.43 1
Abbott Laboratories $37.04 1
Amgen Inc. $22.07 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $134.85 2
PY2022 $754.68 8
PY2023 $1,257.29 13
PY2024 $948.78 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $37.04 03/26/2024 Food and Beverage Undisputed 01/23/2026 1125134724 CMS
ABBVIE INC. $77.07 04/08/2024 Food and Beverage Undisputed 01/23/2026 1107016866 CMS
ABBVIE INC. $116.42 06/25/2024 Food and Beverage Undisputed 01/23/2026 1107016868 CMS
ABBVIE INC. $124.99 09/09/2024 Food and Beverage Undisputed 01/23/2026 1107016870 CMS
Amgen Inc. $22.07 08/21/2024 Food and Beverage Undisputed 01/23/2026 1117540652 CMS
AstraZeneca Pharmaceuticals LP $121.24 06/19/2024 Food and Beverage Undisputed 01/23/2026 1105303592 CMS
Boston Scientific Corporation $90.39 08/12/2024 Food and Beverage Undisputed 01/23/2026 1092435467 CMS
Corcept Therapeutics $9.58 10/29/2024 Food and Beverage Undisputed 01/23/2026 1117743288 CMS
Corcept Therapeutics $23.42 10/30/2024 Food and Beverage Undisputed 01/23/2026 1117743286 CMS
Corcept Therapeutics $7.17 11/12/2024 Food and Beverage Undisputed 01/23/2026 1117743294 CMS
Corcept Therapeutics $9.01 12/02/2024 Food and Beverage Undisputed 01/23/2026 1117743312 CMS
Corcept Therapeutics $100.00 12/09/2024 Food and Beverage Undisputed 01/23/2026 1117743320 CMS
Neurocrine Biosciences, Inc. $124.95 02/12/2024 Food and Beverage Undisputed 01/23/2026 1150921359 CMS
SANOFI-AVENTIS U.S. LLC $85.43 03/11/2024 Food and Beverage Undisputed 01/23/2026 1139881398 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.